Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Return on Equity (2016 - 2026)

Gyre Therapeutics has reported Return on Equity over the past 15 years, most recently at 0.0% for Q4 2025.

  • Quarterly Return on Equity changed 0.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 1.0% down from the prior year.
  • Return on Equity was 0.0% for Q4 2025 at Gyre Therapeutics, down from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q1 2023 and troughed at 0.02% in Q1 2022.
  • The 5-year median for Return on Equity is 0.0% (2023), against an average of 0.01%.
  • Year-over-year, Return on Equity rose 2bps in 2022 and then decreased -2bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.01% in 2021, then soared by 106bps to 0.0% in 2022, then plummeted by -2128bps to 0.02% in 2023, then skyrocketed by 111bps to 0.0% in 2024, then tumbled by -146bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Return on Equity are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).